miR-200b precursor can ameliorate renal tubulointerstitial fibrosis. - Wikidata - wikimedia - TriplyDB

miR-200b precursor can ameliorate renal tubulointerstitial fibrosis.

miR-200b precursor can ameliorate renal tubulointerstitial fibrosis.

http://www.wikidata.org/entity/Q33737756

about

TGF-β/Smad signaling in renal fibrosis MiRNAs in kidney transplantation: potential role as new biomarkers.The relationship between amniotic fluid miRNAs and congenital obstructive nephropathy The roles of microRNA families in hepatic fibrosis.Hypoxia-induced down-regulation of microRNA-34a promotes EMT by targeting the Notch signaling pathway in tubular epithelial cells.An integrated analysis of the SOX2 microRNA response program in human pluripotent and nullipotent stem cell lines.MicroRNA-324-3p promotes renal fibrosis and is a target of ACE inhibition A useful method of identifying of miRNAs which can down-regulate Zeb-2.miRNA expression profile analysis in kidney of different porcine breeds MicroRNAs in renal fibrosis.Cardiac insulin resistance and microRNA modulators.A microrna screen to identify regulators of peritoneal fibrosis in a rat model of peritoneal dialysis.Inhibiting microRNA-192 ameliorates renal fibrosis in diabetic nephropathy.MicroRNAs and the glomerulus Renal interstitial fibrosis: mechanisms and evaluation.Implication of the miR-184 and miR-204 competitive RNA network in control of mouse secondary cataract.Mitochondria and Oxidative Stress in the Cardiorenal Metabolic Syndrome.Potential application of miRNAs as diagnostic and therapeutic tools in chronic pancreatitis.Role of MicroRNAs in Fibrosis.MicroRNAs and fibrosis miR-200c is aberrantly expressed in leiomyomas in an ethnic-dependent manner and targets ZEBs, VEGFA, TIMP2, and FBLN5.In vivo site-specific transfection of naked plasmid DNA and siRNAs in mice by using a tissue suction device MicroRNA circuits in transforming growth factor-β actions and diabetic nephropathy.Effect of dietary salt on regulation of TGF-β in the kidney.Identification of biological targets of therapeutic intervention for clear cell renal cell carcinoma based on bioinformatics approach Stromal miR-200s contribute to breast cancer cell invasion through CAF activation and ECM remodeling.MicroRNA and nephropathy: emerging concepts.MicroRNA-22 is a master regulator of bone morphogenetic protein-7/6 homeostasis in the kidney.From cellular senescence to age-associated diseases: the miRNA connection.Biochemical role of the collagen-rich tumour microenvironment in pancreatic cancer progression.MicroRNAs, transforming growth factor beta-1, and tissue fibrosis.Role of the endothelial-to-mesenchymal transition in renal fibrosis of chronic kidney disease.MicroRNAs: their involvement in fibrosis pathogenesis and use as diagnostic biomarkers in scleroderma.The physical basis of renal fibrosis: effects of altered hydrodynamic forces on kidney homeostasis.Role of microRNA machinery in kidney fibrosis.MicroRNAs: New therapeutic targets for intestinal barrier dysfunction.Transcription regulation of E-cadherin by zinc finger E-box binding homeobox proteins in solid tumors The emerging role of miRNAs in inflammatory bowel disease: a review.miRNAs in urine: a mirror image of kidney disease?MicroRNAs and the regulation of aldosterone signaling in the kidney.

P2860

Q26851198-E2842F8E-5510-4D5C-A849-DAB17DC04D31 Q30456341-8A0FEF69-3C73-40E6-86E7-37985A4BC244 Q33623125-89C6F13F-48A4-487A-A957-B7D8587E537E Q33868794-39773C8C-0269-41CE-8DB5-41F1CC871C43 Q34170239-4C48C453-23F6-4CE0-A3EB-0C5E5FB5DA73 Q34174419-CDD6F014-9AEF-45B4-A2ED-018C0D8A14D3 Q34347713-6BD3FD4A-A924-4F43-838C-AFCB1A0EE609 Q34478153-8217CAFE-98A8-4CE6-8675-DEC81AB15EA9 Q34571730-FE911C06-B948-49EB-8665-C26B0BFA9718 Q35104478-0C3B377E-0702-428F-8EC3-DA52D1EE6F7B Q35251097-3C062F33-584A-4A9F-B803-DBF2FBB45201 Q35605375-8F543D52-DA48-47FE-B9AD-C3751759D2A2 Q35804221-C59BF86E-D98E-46B3-ABAB-6DE1D0D98BC2 Q35907222-2B54867A-EAD6-48D1-857E-3D22956B382B Q35967489-34EFFEC3-CA72-47EB-A6D3-D8CAD3E03A18 Q35973315-05BD1E92-B5ED-4AE9-BDF4-EBBE55F1A533 Q35976043-19CDC7BC-7D25-44B9-8A87-C51CBF4A53BF Q36057439-3DD68643-E6D4-404E-988D-2E6C210879FA Q36093326-857BDA1C-AF0C-4E2E-B804-93B4DBF9F487 Q36103009-ED36EC4A-4A1C-4BD3-B1C6-448A60B16B97 Q36108865-F538F435-3E2A-45D8-BA4B-9FC127AB4BB8 Q36109687-F43B5C3A-77CA-441C-AD12-DC987635CA8B Q36124250-57811BE1-98ED-4C6D-BEA1-8F855F1BF409 Q36125220-F68BAE98-C797-4115-ADA9-AFD93095F636 Q36646189-47661F2F-D6EB-46A7-967D-987CC50D9A00 Q36751290-32858C9E-67B5-424B-92FB-146420264A45 Q37221074-6371EF4C-3E7F-4A14-A357-6738CAA8112D Q37404962-EC4B3FB7-32C1-446B-9CF9-D8C944D79CED Q37581213-BADCBDE3-A561-4A53-A1DD-1AD8DF881B11 Q37970379-14B701A8-A2B5-486D-9DCD-62649B9D69F1 Q38050081-E4B32380-116F-4981-9D67-58128C0C89AB Q38083596-BB5C879A-9E71-450B-B4D1-9355B761F058 Q38139865-8F7972EA-FB43-41B0-9F70-3DF7A82C2108 Q38172403-4C53EC92-6126-4150-949F-887C87A10408 Q38209551-A0E8D7F0-7341-4A17-ACC8-D0F73105FBD4 Q38219024-77DD2DAA-92D7-4E84-9A87-10B925B53006 Q38246793-6C560368-FD1D-4011-8F8F-0DBD6C0CA968 Q38305049-12813F4B-3DA0-420D-BDAF-59B1E096C6CE Q38347455-5085F2BD-5F6E-48F7-B657-E72D8733BD6B Q38352389-30F7DF87-F86C-4D91-A971-2A61FD8D4A85

P2860

miR-200b precursor can ameliorate renal tubulointerstitial fibrosis.

http://www.wikidata.org/entity/Q33737756

description

2010 nî lūn-bûn

@nan

2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

miR-200b precursor can ameliorate renal tubulointerstitial fibrosis.

@ast

miR-200b precursor can ameliorate renal tubulointerstitial fibrosis.

@en

type

label

miR-200b precursor can ameliorate renal tubulointerstitial fibrosis.

@ast

miR-200b precursor can ameliorate renal tubulointerstitial fibrosis.

@en

prefLabel

miR-200b precursor can ameliorate renal tubulointerstitial fibrosis.

@ast

miR-200b precursor can ameliorate renal tubulointerstitial fibrosis.

@en

P1433

Q33737756-A0424853-C5EF-4598-B3CD-6F780DA43C33

P1476

Q33737756-69E9190F-8E06-42CA-B78F-B18F34D0DD86

P2093

Q33737756-0D3683D4-6D95-48E2-8554-B62EF676E076

Q33737756-1A9373A6-5FBC-4132-AD20-3BACD2D10835

Q33737756-290ED131-94B4-4F99-A325-4FB3DF1C4711

Q33737756-545994AD-0959-4A67-9BC1-029F5564E087

Q33737756-6FDBA0E4-A8E8-493A-BB1F-405F1C070294

Q33737756-8108A0DA-22B5-4EC6-9FFC-6161D651BA85

Q33737756-819FF7BB-6280-4CD9-97F8-1C45FE97481B

Q33737756-84C30C69-8F7A-46D2-BD90-C801F7C9764C

Q33737756-CE38A14E-4BC1-43CE-A558-11AA98843BBD

Q33737756-DED4D4B8-1657-47EE-AF0E-9CA2315EE187

P2860

Q33737756-1B77D675-C602-48F4-BA6E-3B7D40DFC02D

Q33737756-26B90C08-E9CF-41AC-9A6F-FB47C6BD636C

Q33737756-349FC45B-AFE2-4374-B645-270ABFBF1A57

Q33737756-356E2FE1-A831-4FF8-B1A3-9894BC50E076

Q33737756-45C049E5-24F1-42FB-A04F-E16664799E7E

Q33737756-5A8112E9-B542-411A-A62F-01164EB39D56

Q33737756-7D5D1CE8-0CA5-44C0-B7A4-F2C04C766495

Q33737756-7F1D5FCC-4AE6-4DDE-85CC-285EFF2FDF44

Q33737756-7FC119F4-2E08-453A-B877-1A99EB137B5F

Q33737756-818567C8-7D70-40BB-9FDF-688FA127A0E6

P304

Q33737756-D2D9EFD7-522F-4E11-8C7D-BEFEA169227F

P31

Q33737756-CF37BF45-C5D3-422D-AB5B-051EA39B0D61

P356

Q33737756-25953FA9-976B-470F-BCF0-C64EC48DB344

P407

Q33737756-F980F632-D4B2-408F-8535-CCD2D5E75F91

P433

Q33737756-A3D39473-7B96-4998-8E7E-DF1A9BAB0765

P478

Q33737756-3AEC6E6F-5EDD-46E7-9E32-26A812E521D1

P50

Q33737756-B8392F2B-BE8B-49C7-8A05-C80CCDCF5E69

P577

Q33737756-4033D64A-09B4-4D7B-9440-A76604643763

P5875

Q33737756-2ECD6867-D0B0-4229-9198-26FD70446EA7

P698

Q33737756-52535E0E-4CE6-4613-A88E-8B550A8065D0

P932

Q33737756-400E5C6D-C875-40C3-B79A-48910F465FFA

P356

JOURNAL.PONE.0013614

P1433

P1476

miR-200b precursor can ameliorate renal tubulointerstitial fibrosis.

@en

P2093

Etsu Suzuki

http://www.w3.org/2001/XMLSchema#string

Hajime Takamori

http://www.w3.org/2001/XMLSchema#string

Hiroaki Nishimatsu

http://www.w3.org/2001/XMLSchema#string

Kenichiro Sato

http://www.w3.org/2001/XMLSchema#string

Kenjiro Kimura

http://www.w3.org/2001/XMLSchema#string

Masatoshi Kasuya

http://www.w3.org/2001/XMLSchema#string

Shigeyoshi Oba

http://www.w3.org/2001/XMLSchema#string

Shintaro Kumano

http://www.w3.org/2001/XMLSchema#string

Toshiro Fujita

http://www.w3.org/2001/XMLSchema#string

Yasunobu Hirata

http://www.w3.org/2001/XMLSchema#string

P2860

The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2

A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells

The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1

Epithelial-mesenchymal transitions in development and pathologies

Evidence that fibroblasts derive from epithelium during tissue fibrosis

A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition

The role of Toll-like receptor 2 in inflammation and fibrosis during progressive renal injury.

MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors.

The role of interstitial cells in the progression of renal diseases.

Tubulointerstitial changes as a major determinant in the progression of renal damage.

P304

e13614

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0013614

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Masao Takahashi

P577

2010-10-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47676789

http://www.w3.org/2001/XMLSchema#string

P698

21049046

http://www.w3.org/2001/XMLSchema#string

P932

2963611

http://www.w3.org/2001/XMLSchema#string